• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 2; SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 2; SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER Back to Search Results
Device Problem Therapeutic or Diagnostic Output Failure (3023)
Patient Problem Insufficient Information (4580)
Event Type  malfunction  
Event Description
I have attempted to use the abbott labs freestyle libre 2 gsm and have had 5 out of 5 sensor failures.I placed the first sensor correctly and had it work for the entire 14-day life cycle.After replacement of 5 failed sensors and 1 reader, how could the freestyle libre 2 system be considered effective with a 100% sensor failure rate? the sensor failures happen within the first hour of initialization between the reader and the sensor.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
SYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER
Manufacturer (Section D)
ABBOTT DIABETES CARE INC.
MDR Report Key14592448
MDR Text Key293341689
Report NumberMW5110065
Device Sequence Number1
Product Code NBW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 05/31/2022
6 Devices were Involved in the Event: 1   2   3   4   5   6  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/02/2022
Patient Sequence Number1
Treatment
LISINOPRIL - 20 MG PER DAY; VITAMIN D3 - 5000 UNITS PER DAY
Patient Age55 YR
Patient SexMale
Patient Weight134 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-